Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elevance Health, Inc.ANTM · Entity 2934 | EVP & Chief HR Officer | March 01, 2018 | March 05, 2018 |
| LyondellBasell Industries N.V.LYB · Entity 3246 | SVP, Human Resources | February 20, 2017 | February 23, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elevance Health, Inc.
Report date March 01, 2018 · Filed March 05, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,105 |
Reported balance
After 2018-03-01 transaction · row 1
1 source rowRow 1 · 2018-03-01 · Grant · Acquired 2,155 · Balance 3,105 F1: Represents restricted share units. Restrictions lapse as follows: 718 shares each on 3/1/2019 and 3/1/2020, and 719 on 3/1/2021. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $232.04 · Expires 2028-03-01 | Direct | 9,082 |
Reported balance
After 2018-03-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-03-01 · Grant · Acquired 9,082 · Balance 9,082 F2: The option represents a right to purchase a total of 9,082 shares, and is exercisable in six semi-annual installments, with two installments of 1,513 shares each and four installments of 1,514 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted share units. Restrictions lapse as follows: 718 shares each on 3/1/2019 and 3/1/2020, and 719 on 3/1/2021.
F2: The option represents a right to purchase a total of 9,082 shares, and is exercisable in six semi-annual installments, with two installments of 1,513 shares each and four installments of 1,514 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date.
LyondellBasell Industries N.V.
Report date February 20, 2017 · Filed February 23, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A ordinary sharesSEC Table I · non-derivative | Direct | 16,514 |
Last balance in matching sequence
After 2017-02-22 transaction · row 6
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
6 source rowsRow 1 · 2017-02-20 · Tax withholding · Disposed 441 · Balance 16,514 F1: Includes 7,478 restricted stock units ("RSUs") granted pursuant to the issuer's long-term incentive plan: 939 granted on September 1, 2012 vest on September 1, 2017; 2,287 granted on February 12, 2013 vest on February 12, 2018; 1,845 granted on February 17, 2015 that vest on February 17, 2018 and 2,407 granted on February 16, 2016 that vest on February 16, 2019. Row 2 · 2017-02-22 · Exercise / conversion · Acquired 4,518 · Balance 21,032 F1: Includes 7,478 restricted stock units ("RSUs") granted pursuant to the issuer's long-term incentive plan: 939 granted on September 1, 2012 vest on September 1, 2017; 2,287 granted on February 12, 2013 vest on February 12, 2018; 1,845 granted on February 17, 2015 that vest on February 17, 2018 and 2,407 granted on February 16, 2016 that vest on February 16, 2019. Row 3 · 2017-02-22 · Exercise / conversion · Acquired 4,169 · Balance 25,201 F1: Includes 7,478 restricted stock units ("RSUs") granted pursuant to the issuer's long-term incentive plan: 939 granted on September 1, 2012 vest on September 1, 2017; 2,287 granted on February 12, 2013 vest on February 12, 2018; 1,845 granted on February 17, 2015 that vest on February 17, 2018 and 2,407 granted on February 16, 2016 that vest on February 16, 2019. Row 4 · 2017-02-22 · Exercise / conversion · Acquired 3,112 · Balance 28,313 F1: Includes 7,478 restricted stock units ("RSUs") granted pursuant to the issuer's long-term incentive plan: 939 granted on September 1, 2012 vest on September 1, 2017; 2,287 granted on February 12, 2013 vest on February 12, 2018; 1,845 granted on February 17, 2015 that vest on February 17, 2018 and 2,407 granted on February 16, 2016 that vest on February 16, 2019. Row 5 · 2017-02-22 · Exercise / conversion · Acquired 2,970 · Balance 31,283 F1: Includes 7,478 restricted stock units ("RSUs") granted pursuant to the issuer's long-term incentive plan: 939 granted on September 1, 2012 vest on September 1, 2017; 2,287 granted on February 12, 2013 vest on February 12, 2018; 1,845 granted on February 17, 2015 that vest on February 17, 2018 and 2,407 granted on February 16, 2016 that vest on February 16, 2019. Row 6 · 2017-02-22 · Sale · Disposed 14,769 · Balance 16,514 F2: This transaction was executed in multiple trades at prices ranging from $94.00 to $94.06. The price reported above reflects the weighted-average sale price. The reporting person herby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1: Includes 7,478 restricted stock units ("RSUs") granted pursuant to the issuer's long-term incentive plan: 939 granted on September 1, 2012 vest on September 1, 2017; 2,287 granted on February 12, 2013 vest on February 12, 2018; 1,845 granted on February 17, 2015 that vest on February 17, 2018 and 2,407 granted on February 16, 2016 that vest on February 16, 2019. |
| Opt - Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $60.51 · Expires 2023-02-12 | Direct | 0 |
Reported balance
After 2017-02-22 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-02-22 · Exercise / conversion · Disposed 4,169 · Balance 0 F3: Granted pursuant to the issuer's long-term incentive plan. The option was originally granted on February 12, 2013 and vested in three equal installments on the 1st, 2nd and 3rd anniversaries of the date of grant. |
| Opt - Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $77.93 · Expires 2026-02-16 | Direct | 6,222 |
Reported balance
After 2017-02-22 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-02-22 · Exercise / conversion · Disposed 3,112 · Balance 6,222 F4: Granted pursuant to the issuer's long-term incentive plan. Award vests as follows: 3,112 vested on February 16, 2017; 3,111 vest on February 16, 2018 and 3,111 vest on February 16, 2019. |
| Opt - Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $89.94 · Expires 2025-02-17 | Direct | 2,259 |
Reported balance
After 2017-02-22 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2017-02-22 · Exercise / conversion · Disposed 4,518 · Balance 2,259 F5: Granted pursuant to the issuer's long-term incentive plan. Award vests in three equal installments on the 1st, 2nd and 3rd anniversaries of the date of grant of February 17, 2015. |
| Opt - Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $85.80 · Expires 2017-02-20 | Direct | 0 |
Reported balance
After 2017-02-22 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2017-02-22 · Exercise / conversion · Disposed 2,970 · Balance 0 F6: Granted pursuant to the issuer's long-term incentive plan. The option was originally granted on February 20, 2014 and vested in three equal installments on the 1st, 2nd and 3rd anniversaries of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 7,478 restricted stock units ("RSUs") granted pursuant to the issuer's long-term incentive plan: 939 granted on September 1, 2012 vest on September 1, 2017; 2,287 granted on February 12, 2013 vest on February 12, 2018; 1,845 granted on February 17, 2015 that vest on February 17, 2018 and 2,407 granted on February 16, 2016 that vest on February 16, 2019.
F2: This transaction was executed in multiple trades at prices ranging from $94.00 to $94.06. The price reported above reflects the weighted-average sale price. The reporting person herby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Granted pursuant to the issuer's long-term incentive plan. The option was originally granted on February 12, 2013 and vested in three equal installments on the 1st, 2nd and 3rd anniversaries of the date of grant.
F4: Granted pursuant to the issuer's long-term incentive plan. Award vests as follows: 3,112 vested on February 16, 2017; 3,111 vest on February 16, 2018 and 3,111 vest on February 16, 2019.
F5: Granted pursuant to the issuer's long-term incentive plan. Award vests in three equal installments on the 1st, 2nd and 3rd anniversaries of the date of grant of February 17, 2015.
F6: Granted pursuant to the issuer's long-term incentive plan. The option was originally granted on February 20, 2014 and vested in three equal installments on the 1st, 2nd and 3rd anniversaries of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2018 Filed Mar 5, 2018 21:52 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 9,082 | $0.00 Strike: $232.04 | $0.00 |
DisclosureSEC source: 0001127602-18-010116 · form4.xml · derivative · entry 2 Wolf Jacquelyn H · CIK 0001350861 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,082 Underlying: Common Stock · 9,082 shares Expires 2028-03-01 F2 · derivative.exercise_date: The option represents a right to purchase a total of 9,082 shares, and is exercisable in six semi-annual installments, with two installments of 1,513 shares each and four installments of 1,514 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:52 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 2,155 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010116 · form4.xml · nonDerivative · entry 1 Wolf Jacquelyn H · CIK 0001350861 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,105 F1 · shares: Represents restricted share units. Restrictions lapse as follows: 718 shares each on 3/1/2019 and 3/1/2020, and 719 on 3/1/2021. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 20:34 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 3,882 | $0.00 Strike: $197.43 | $0.00 |
DisclosureSEC source: 0001127602-17-027049 · form4.xml · derivative · entry 2 Wolf Jacquelyn H · CIK 0001350861 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,882 Underlying: Common Stock · 3,882 shares Expires 2027-09-01 F2 · derivative.exercise_date: The option represents a right to purchase a total of 3,882 shares, and is exercisable in six semi-annual installments of 647 shares each, beginning on March 1, 2018, which is the six-month anniversary of the option grant date. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 20:34 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 950 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-027049 · form4.xml · nonDerivative · entry 1 Wolf Jacquelyn H · CIK 0001350861 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 950 F1 · shares: Represents restricted share units. Restrictions lapse as follows: 316 shares on 9/1/2018, and 317 shares each on 9/1/2019 and 9/1/2020. Read SEC document |
| February 22, 2017 Filed Feb 23, 2017 01:13 UTC | LyondellBasell Industries N.V. LYB · Entity 3246 | Exercise / conversionOpt - Stock Option · Derivative | 2,970 | $0.00 Strike: $85.80 | $0.00 |
DisclosureSEC source: 0001225208-17-004193 · doc4.xml · derivative · entry 10 Wolf Jacquelyn H · CIK 0001350861 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A ordinary shares · 2,970 shares Expires 2017-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Granted pursuant to the issuer's long-term incentive plan. The option was originally granted on February 20, 2014 and vested in three equal installments on the 1st, 2nd and 3rd anniversaries of the date of grant. Read SEC document |
| February 22, 2017 Filed Feb 23, 2017 01:13 UTC | LyondellBasell Industries N.V. LYB · Entity 3246 | Exercise / conversionOpt - Stock Option · Derivative | 4,518 | $0.00 Strike: $89.94 | $0.00 |
DisclosureSEC source: 0001225208-17-004193 · doc4.xml · derivative · entry 9 Wolf Jacquelyn H · CIK 0001350861 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,259 Underlying: Class A ordinary shares · 4,518 shares Expires 2025-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Granted pursuant to the issuer's long-term incentive plan. Award vests in three equal installments on the 1st, 2nd and 3rd anniversaries of the date of grant of February 17, 2015. Read SEC document |
| February 22, 2017 Filed Feb 23, 2017 01:13 UTC | LyondellBasell Industries N.V. LYB · Entity 3246 | Exercise / conversionOpt - Stock Option · Derivative | 3,112 | $0.00 Strike: $77.93 | $0.00 |
DisclosureSEC source: 0001225208-17-004193 · doc4.xml · derivative · entry 8 Wolf Jacquelyn H · CIK 0001350861 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,222 Underlying: Class A ordinary shares · 3,112 shares Expires 2026-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Granted pursuant to the issuer's long-term incentive plan. Award vests as follows: 3,112 vested on February 16, 2017; 3,111 vest on February 16, 2018 and 3,111 vest on February 16, 2019. Read SEC document |
| February 22, 2017 Filed Feb 23, 2017 01:13 UTC | LyondellBasell Industries N.V. LYB · Entity 3246 | Exercise / conversionOpt - Stock Option · Derivative | 4,169 | $0.00 Strike: $60.51 | $0.00 |
DisclosureSEC source: 0001225208-17-004193 · doc4.xml · derivative · entry 7 Wolf Jacquelyn H · CIK 0001350861 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A ordinary shares · 4,169 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Granted pursuant to the issuer's long-term incentive plan. The option was originally granted on February 12, 2013 and vested in three equal installments on the 1st, 2nd and 3rd anniversaries of the date of grant. Read SEC document |
| February 22, 2017 Filed Feb 23, 2017 01:13 UTC | LyondellBasell Industries N.V. LYB · Entity 3246 | SaleClass A ordinary shares | 14,769 | $94.01 | $1,388,415.97 |
DisclosureSEC source: 0001225208-17-004193 · doc4.xml · nonDerivative · entry 6 Wolf Jacquelyn H · CIK 0001350861 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,514 F2 · price: This transaction was executed in multiple trades at prices ranging from $94.00 to $94.06. The price reported above reflects the weighted-average sale price. The reporting person herby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 7,478 restricted stock units ("RSUs") granted pursuant to the issuer's long-term incentive plan: 939 granted on September 1, 2012 vest on September 1, 2017; 2,287 granted on February 12, 2013 vest on February 12, 2018; 1,845 granted on February 17, 2015 that vest on February 17, 2018 and 2,407 granted on February 16, 2016 that vest on February 16, 2019. Read SEC document |
| February 22, 2017 Filed Feb 23, 2017 01:13 UTC | LyondellBasell Industries N.V. LYB · Entity 3246 | Exercise / conversionClass A ordinary shares | 2,970 | $85.80 | $254,826.00 |
DisclosureSEC source: 0001225208-17-004193 · doc4.xml · nonDerivative · entry 5 Wolf Jacquelyn H · CIK 0001350861 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 7,478 restricted stock units ("RSUs") granted pursuant to the issuer's long-term incentive plan: 939 granted on September 1, 2012 vest on September 1, 2017; 2,287 granted on February 12, 2013 vest on February 12, 2018; 1,845 granted on February 17, 2015 that vest on February 17, 2018 and 2,407 granted on February 16, 2016 that vest on February 16, 2019. Read SEC document |
| February 22, 2017 Filed Feb 23, 2017 01:13 UTC | LyondellBasell Industries N.V. LYB · Entity 3246 | Exercise / conversionClass A ordinary shares | 3,112 | $77.93 | $242,518.16 |
DisclosureSEC source: 0001225208-17-004193 · doc4.xml · nonDerivative · entry 4 Wolf Jacquelyn H · CIK 0001350861 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 7,478 restricted stock units ("RSUs") granted pursuant to the issuer's long-term incentive plan: 939 granted on September 1, 2012 vest on September 1, 2017; 2,287 granted on February 12, 2013 vest on February 12, 2018; 1,845 granted on February 17, 2015 that vest on February 17, 2018 and 2,407 granted on February 16, 2016 that vest on February 16, 2019. Read SEC document |
| February 22, 2017 Filed Feb 23, 2017 01:13 UTC | LyondellBasell Industries N.V. LYB · Entity 3246 | Exercise / conversionClass A ordinary shares | 4,169 | $60.51 | $252,266.19 |
DisclosureSEC source: 0001225208-17-004193 · doc4.xml · nonDerivative · entry 3 Wolf Jacquelyn H · CIK 0001350861 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 7,478 restricted stock units ("RSUs") granted pursuant to the issuer's long-term incentive plan: 939 granted on September 1, 2012 vest on September 1, 2017; 2,287 granted on February 12, 2013 vest on February 12, 2018; 1,845 granted on February 17, 2015 that vest on February 17, 2018 and 2,407 granted on February 16, 2016 that vest on February 16, 2019. Read SEC document |
| February 22, 2017 Filed Feb 23, 2017 01:13 UTC | LyondellBasell Industries N.V. LYB · Entity 3246 | Exercise / conversionClass A ordinary shares | 4,518 | $89.94 | $406,348.92 |
DisclosureSEC source: 0001225208-17-004193 · doc4.xml · nonDerivative · entry 2 Wolf Jacquelyn H · CIK 0001350861 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 7,478 restricted stock units ("RSUs") granted pursuant to the issuer's long-term incentive plan: 939 granted on September 1, 2012 vest on September 1, 2017; 2,287 granted on February 12, 2013 vest on February 12, 2018; 1,845 granted on February 17, 2015 that vest on February 17, 2018 and 2,407 granted on February 16, 2016 that vest on February 16, 2019. Read SEC document |
| February 20, 2017 Filed Feb 23, 2017 01:13 UTC | LyondellBasell Industries N.V. LYB · Entity 3246 | Tax withholdingClass A ordinary shares | 441 | $92.91 | $40,973.31 |
DisclosureSEC source: 0001225208-17-004193 · doc4.xml · nonDerivative · entry 1 Wolf Jacquelyn H · CIK 0001350861 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,514 F1 · balance_after: Includes 7,478 restricted stock units ("RSUs") granted pursuant to the issuer's long-term incentive plan: 939 granted on September 1, 2012 vest on September 1, 2017; 2,287 granted on February 12, 2013 vest on February 12, 2018; 1,845 granted on February 17, 2015 that vest on February 17, 2018 and 2,407 granted on February 16, 2016 that vest on February 16, 2019. Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 00:35 UTC | LyondellBasell Industries N.V. LYB · Entity 3246 | Tax withholdingClass A ordinary shares | 1,167 | $92.69 | $108,169.23 |
DisclosureSEC source: 0001225208-17-004033 · doc4.xml · nonDerivative · entry 2 Wolf Jacquelyn H · CIK 0001350861 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,955 F3 · shares: Represents shares required to satisfy tax withholding obligations in connection with the vesting of 4,190 shares of performance-based stock granted to the Reporting Person on February 20, 2014. F2 · balance_after: Includes 9,090 restricted stock units ("RSUs") granted pursuant to the issuer's long-term incentive plan: 939 granted on September 1, 2012 vest on September 1, 2017; 2,287 granted on February 12, 2013 vest on February 12, 2018; 1,612 granted on February 20, 2014 vest on February 20, 2017; 1,845 granted on February 17, 2015 that vest on February 17, 2018 and 2,407 granted on February 16, 2016 that vest on February 16, 2019. Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 00:35 UTC | LyondellBasell Industries N.V. LYB · Entity 3246 | GrantClass A ordinary shares | 4,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-004033 · doc4.xml · nonDerivative · entry 1 Wolf Jacquelyn H · CIK 0001350861 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,122 F1 · shares: Represents shares earned in connection with the performance-based stock previously granted and unreportable on February 20, 2014 pursuant to the issuer's long-term incentive plan. Shares were earned based upon the level of attainment of certain performance objectives and continued employment. These shares fully vested on February 16, 2017 following certification by the Issuer's compensation committee. F2 · balance_after: Includes 9,090 restricted stock units ("RSUs") granted pursuant to the issuer's long-term incentive plan: 939 granted on September 1, 2012 vest on September 1, 2017; 2,287 granted on February 12, 2013 vest on February 12, 2018; 1,612 granted on February 20, 2014 vest on February 20, 2017; 1,845 granted on February 17, 2015 that vest on February 17, 2018 and 2,407 granted on February 16, 2016 that vest on February 16, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.